Find a Therapeutic By Name

Search By Attributes

Therapy Type

Combination
DNA/RNA-based
Immunotherapy (active)
Immunotherapy (passive)
Other
Procedural Intervention
Small Molecule
Supplement, Dietary

Condition

Alzheimer's Disease
Amyotrophic Lateral Sclerosis
Cerebral Amyloid Angiopathy
Frontotemporal Dementia
Mild Cognitive Impairment
Parkinson's Disease

Keyword

1 Therapeutic

Search Results

Name	Synonyms	FDA Status	Company	Target Type	Therapy Type	Approved For
Relyvrio	Albrioza, AMX0035	Amyotrophic Lateral Sclerosis (Withdrawn), Alzheimer's Disease (Inactive), Progressive Supranuclear Palsy (Discontinued)	Amylyx Pharmaceuticals Inc	Other	Combination, Small Molecule	ALS